US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BillionToOne, Inc.

88.73

-5.9900-6.32%

Post-market: 88.730.00000.00%19:52 EST

Volume:622.54K

Turnover:56.65M

Market Cap:4.03B

PE:-82.62

High:95.35

Open:95.00

Low:85.53

Close:94.72

52wk High:138.70

52wk Low:80.51

Shares:45.40M

Float Shares:3.85M

Volume Ratio:2.40

T/O Rate:16.19%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0740

EPS(LYR):-4.1240

ROE:--

ROA:--

PB:-16.82

PE(LYR):-21.52

Loading ...

Overview Company News Filings

BRIEF-Billiontoone Announces Collaboration With Epic To Expand Prenatal And Oncology Testing Across Healthcare

BillionToOne Integrates Prenatal and Oncology Tests with Epic EHR

Billiontoone Announces Collaboration With Epic to Expand Prenatal and Oncology Testing Across Healthcare

THOMSON REUTERS

What's Going On With BillionToOne Shares Tuesday?

Benzinga_recent_news

BillionToOne: Reaffirmed Growth Targets and Upside to 2026 Support Reiterated Buy Rating

BillionToOne Reaffirms 2025 Revenue Guidance, Issues 2026 Guidance

MT Newswires Live

BillionToOne Issues Strong 2026 Growth and Profit Outlook

GUIDANCE: (BLLN) BillionToOne Expects 2026 Total Revenue Range $415M to $430M, vs. FactSet Est of $402.3M

MT Newswires Live

BillionToOne sees FY26 revenue $415M-$430M, consensus $393.61M

BRIEF-Billiontoone Provides Guidance For 2026

BillionToOne Projects 2026 Revenue Up to $430 Million with Positive Operating Income

Billiontoone Inc FY2025 REV View $296.2 Mln -- Lseg Ibes Data

THOMSON REUTERS

Billiontoone Provides Guidance for 2026

THOMSON REUTERS

Billiontoone Inc FY2026 REV View $402.4 Mln -- Lseg Ibes Data

THOMSON REUTERS

BillionToOne Provides Guidance for 2026

BRIEF-Billiontoone Announces Selection Of Northstar Select® As The New Liquid Biopsy Test

BillionToOne Partners with National Cancer Center Hospital East for Liquid Biopsy Study in Japan

Billiontoone- Ultra-Sensitive Liquid Biopsy Expanding Precision Medicine Access in Japan With Treatment-Resistant Non-Small Cell Lung Cancer

THOMSON REUTERS

Billiontoone Announces Selection of Northstar Select® as the New Liquid Biopsy Test for Lc-Scrum-TRY Clinical Study at National Cancer Center Hospital East

THOMSON REUTERS

Guggenheim Initiates BillionToOne at Buy With $120 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BLLN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","market":"US","secType":"STK","nameCN":"BillionToOne, Inc.","latestPrice":88.73,"timestamp":1768597200000,"preClose":94.72,"halted":0,"volume":622535,"hourTrading":{"tag":"盘后","latestPrice":88.73,"preClose":88.73,"latestTime":"19:52 EST","volume":13308,"amount":1184618.91,"timestamp":1768611148972,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.06323902027027022,"floatShares":3846000,"shares":45403000,"eps":-1.073956,"marketStatus":"Market Closed","change":-5.99,"latestTime":"01-16 16:00:00 EST","open":95,"high":95.35,"low":85.53,"amount":56654849.75915,"amplitude":0.103674,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.073956,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"listingDate":1762405200000,"exchange":"NASDAQ","adjPreClose":94.72,"preHourTrading":{"tag":"盘前","latestPrice":94.5,"preClose":94.72,"latestTime":"09:12 EST","volume":1560,"amount":149063.616,"timestamp":1768572739088,"change":-0.22,"changeRate":-0.002323,"amplitude":0.029455},"postHourTrading":{"tag":"盘后","latestPrice":88.73,"preClose":88.73,"latestTime":"19:52 EST","volume":13308,"amount":1184618.91,"timestamp":1768611148972,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.404792938336521},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","floatShares":3846000,"roa":"--","roe":"--","lyrEps":-4.124007,"volumeRatio":2.404792938336521,"shares":45403000,"dividePrice":0,"high":95.35,"amplitude":0.103674,"preClose":94.72,"low":85.53,"week52Low":80.51,"pbRate":"-16.82","psRate":"15.85","week52High":138.7,"institutionHeld":0,"latestPrice":88.73,"eps":-1.073956,"divideRate":0,"volume":622535,"delay":0,"ttmEps":-1.073956,"open":95,"prevYearClose":81.84,"prevWeekClose":85.94,"prevMonthClose":81.84,"prevQuarterClose":81.84,"fiveDayClose":85.94,"twentyDayClose":92.51,"sixtyDayClose":60},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLLN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":8,"updateTime":1767762000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLLN","date":"2026-01-16","current":-82.619772,"percent":0.25,"low":-448.462026,"twenty":-392.928663,"median":-348.806737,"eighty":-150.668895,"high":-87.827147,"avg":-276.983775,"sd":118.008866,"marketCap":4335216947},"quantilePoints":[{"date":"2025-11-07","current":-159.132389,"twenty":-144.871341,"median":-123.479768,"eighty":-102.088195,"marketCap":4871838088},{"date":"2025-11-14","current":-130.808752,"twenty":-151.11734,"median":-148.702746,"eighty":-133.870451,"marketCap":4004709939},{"date":"2025-11-21","current":-139.763053,"twenty":-149.199396,"median":-143.65591,"eighty":-132.43601,"marketCap":4278845862},{"date":"2025-11-28","current":-193.061188,"twenty":-160.680767,"median":-147.409996,"eighty":-136.31572,"marketCap":5910568267},{"date":"2025-12-05","current":-154.265054,"twenty":-170.43011,"median":-151.565786,"eighty":-139.763053,"marketCap":4722824636},{"date":"2025-12-12","current":-402.174044,"twenty":-192.645939,"median":-154.739624,"eighty":-142.260908,"marketCap":4459707974},{"date":"2025-12-19","current":-394.166884,"twenty":-381.825952,"median":-160.680767,"eighty":-145.050911,"marketCap":4370916580},{"date":"2025-12-26","current":-356.359883,"twenty":-394.819014,"median":-167.642009,"eighty":-145.90398,"marketCap":3951674738},{"date":"2026-01-02","current":-337.786574,"twenty":-386.762325,"median":-177.845273,"eighty":-147.668546,"marketCap":3745715318},{"date":"2026-01-09","current":-361.519135,"twenty":-391.80601,"median":-193.061188,"eighty":-149.075233,"marketCap":4008885688},{"date":"2026-01-16","current":-390.947511,"twenty":-392.928663,"median":-348.806737,"eighty":-150.668895,"marketCap":4335216947}],"updateTime":1768720328948},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLLN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603137983","title":"BRIEF-Billiontoone Announces Collaboration With Epic To Expand Prenatal And Oncology Testing Across Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2603137983","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603137983?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:59","pubTimestamp":1768485599,"startTime":"0","endTime":"0","summary":"BRIEF-Billiontoone Announces Collaboration With Epic To Expand Prenatal And Oncology Testing Across HealthcareJan 15 (Reuters) - BillionToOne Inc BLLN.O:BILLIONTOONE ANNOUNCES COLLABORATION WITH EPIC ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nTUA7BMNPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2603398310","title":"BillionToOne Integrates Prenatal and Oncology Tests with Epic EHR","url":"https://stock-news.laohu8.com/highlight/detail?id=2603398310","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603398310?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:59","pubTimestamp":1768485560,"startTime":"0","endTime":"0","summary":"BillionToOne Inc., a molecular diagnostics company, has announced a collaboration with Epic, the widely used electronic health record  provider. This partnership will integrate BillionToOne's UNITY Complete prenatal test and Northstar oncology liquid biopsy tests into Epic's Aura diagnostics suite. Clinicians will be able to order these tests directly within Epic, with results delivered seamlessly into the EHR and accessible via the MyChart patient portal. The integration aims to streamline clinical workflows, enhance patient and provider experiences, and support faster clinical decision-making in both prenatal and oncology care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Billiontoone Inc. published the original content used to gen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL3BlHw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2603454983","title":"Billiontoone Announces Collaboration With Epic to Expand Prenatal and Oncology Testing Across Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2603454983","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603454983?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:59","pubTimestamp":1768485543,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nTUA7BMNPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2603633514","title":"What's Going On With BillionToOne Shares Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603633514","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603633514?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:43","pubTimestamp":1768315380,"startTime":"0","endTime":"0","summary":"BillionToOne shares traded higher premarket on possible continued momentum Tuesday before flattening at the beginning of the session.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/13/Stock-chartbenzingaai2023-stock-market-c.png?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/13/Stock-chartbenzingaai2023-stock-market-c.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/01/49875584/whats-going-on-with-billiontoone-shares-tuesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/01/49875584/whats-going-on-with-billiontoone-shares-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2603654579","title":"BillionToOne: Reaffirmed Growth Targets and Upside to 2026 Support Reiterated Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2603654579","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603654579?lang=en_us&edition=fundamental","pubTime":"2026-01-13 10:56","pubTimestamp":1768272985,"startTime":"0","endTime":"0","summary":"William Blair analyst Andrew Brackmann has reiterated their bullish stance on BLLN stock, giving a Buy rating yesterday. Andrew Brackmann has given...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/billiontoone-reaffirmed-growth-targets-and-upside-to-2026-support-reiterated-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/billiontoone-reaffirmed-growth-targets-and-upside-to-2026-support-reiterated-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLLN"],"gpt_icon":0},{"id":"2602454307","title":"BillionToOne Reaffirms 2025 Revenue Guidance, Issues 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2602454307","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602454307?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:04","pubTimestamp":1768226697,"startTime":"0","endTime":"0","summary":"BillionToOne  said Monday it continues to expect 2025 revenue of $293 million to $299 million.Analysts polled by FactSet expect $296.2 million.For 2026, the company expects revenue of $415 million to $430 million, representing growth of 40% to 45% compared with the midpoint of its 2025 guidance range.Analysts surveyed by FactSet expect $402.3 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLLN"],"gpt_icon":0},{"id":"2602548083","title":"BillionToOne Issues Strong 2026 Growth and Profit Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2602548083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602548083?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:34","pubTimestamp":1768224888,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc. Class A ( ($BLLN) ) has shared an update. On January 12, 2026, BillionToOne, Inc. announced financial guidance indicating it exp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/billiontoone-issues-strong-2026-growth-and-profit-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/billiontoone-issues-strong-2026-growth-and-profit-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2602548592","title":"GUIDANCE: (BLLN) BillionToOne Expects 2026 Total Revenue Range $415M to $430M, vs. FactSet Est of $402.3M","url":"https://stock-news.laohu8.com/highlight/detail?id=2602548592","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602548592?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:25","pubTimestamp":1768224347,"startTime":"0","endTime":"0","summary":"GUIDANCE: (BLLN) BillionToOne Expects 2026 Total Revenue Range $415M to $430M, vs. FactSet Est of $402.3M","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TSS","BLLN"],"gpt_icon":0},{"id":"2602510014","title":"BillionToOne sees FY26 revenue $415M-$430M, consensus $393.61M","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510014","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510014?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:15","pubTimestamp":1768223747,"startTime":"0","endTime":"0","summary":"“As we look ahead to 2026, we are excited by the opportunity to further scale our differentiated platform built on innovative science and disciplin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/billiontoone-sees-fy26-revenue-415m-430m-consensus-393-61m-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/billiontoone-sees-fy26-revenue-415m-430m-consensus-393-61m-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLLN"],"gpt_icon":0},{"id":"2602299510","title":"BRIEF-Billiontoone Provides Guidance For 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602299510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602299510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:15","pubTimestamp":1768223716,"startTime":"0","endTime":"0","summary":"BRIEF-Billiontoone Provides Guidance For 2026Jan 12 (Reuters) - BillionToOne Inc BLLN.O:BILLIONTOONE PROVIDES GUIDANCE FOR 20262026 REVENUE GUIDANCE OF $415 MILLION TO $430 MILLIONREITERATES 2025 GUID","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA6TJYRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2602109685","title":"BillionToOne Projects 2026 Revenue Up to $430 Million with Positive Operating Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2602109685","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602109685?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223116,"startTime":"0","endTime":"0","summary":"BillionToOne Inc. has announced its financial guidance for the full year 2026, projecting total revenue between $415 million and $430 million. This represents a significant increase of 40% to 45% compared to the midpoint of its full year 2025 revenue guidance, which was reiterated at $293 million to $299 million. The company also expects to achieve positive GAAP operating income for both 2025 and 2026, highlighting continued growth and improved profitability.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Billiontoone Inc. published the original content used to generate this news brief via GlobeNewswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL2ybVwJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","SG9999014039.USD","BK4585","IE00BKPKM429.USD","BK4196","LU2095319765.USD","LU2210150020.SGD","BK4112","IE00B3QW5Z07.USD","BLLN","LU0314104364.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","NDAQ","IE00BGHQF748.EUR","SG9999014021.USD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2602510670","title":"Billiontoone Inc  FY2025 REV View $296.2 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510670","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510670?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA6TJYRV:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2602510537","title":"Billiontoone Provides Guidance for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510537?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA6TJYRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2602251064","title":"Billiontoone Inc  FY2026 REV View $402.4 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2602251064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602251064?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA6TJYRV:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2602031510","title":"BillionToOne Provides Guidance for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602031510","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602031510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Jan.  12, 2026  (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/12/3216869/0/en/BillionToOne-Provides-Guidance-for-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2601816803","title":"BRIEF-Billiontoone Announces Selection Of Northstar Select® As The New Liquid Biopsy Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2601816803","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601816803?lang=en_us&edition=fundamental","pubTime":"2026-01-06 23:11","pubTimestamp":1767712280,"startTime":"0","endTime":"0","summary":"BRIEF-Billiontoone Announces Selection Of Northstar Select As The New Liquid Biopsy Test Jan 6 (Reuters) - BillionToOne Inc BLLN.O:BILLIONTOONE ANNOUNCES SELECTION OF NORTHSTAR SELECT AS THE NEW LIQUI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA2KWDPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2601881864","title":"BillionToOne Partners with National Cancer Center Hospital East for Liquid Biopsy Study in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2601881864","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601881864?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:01","pubTimestamp":1767708084,"startTime":"0","endTime":"0","summary":"BillionToOne Inc. has announced a collaboration with the National Cancer Center Hospital East  in Japan, as its ultra-sensitive liquid biopsy test, Northstar Select, has been selected for use in the LC-SCRUM-TRY clinical study. This partnership aims to expand precision medicine access for patients with treatment-resistant non-small cell lung cancer  in Japan. By integrating Northstar Select into the nationwide, multi-center study, the collaboration seeks to better characterize drug-resistant cancers and identify more effective therapies for affected patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Billiontoone Inc. published the original content used to generate this news brief via PR Newswire  on January 06, 2026, and is solel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL37XJQv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","BK4135","BLLN","BK4196","BK4160","BK4205","DBRG"],"gpt_icon":0},{"id":"2601818237","title":"Billiontoone- Ultra-Sensitive Liquid Biopsy Expanding Precision Medicine Access in Japan With Treatment-Resistant Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601818237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601818237?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:00","pubTimestamp":1767708008,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA2KWDPY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLLN","BK4196"],"gpt_icon":0},{"id":"2601081860","title":"Billiontoone Announces Selection of Northstar Select® as the New Liquid Biopsy Test for Lc-Scrum-TRY Clinical Study at National Cancer Center Hospital East","url":"https://stock-news.laohu8.com/highlight/detail?id=2601081860","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601081860?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:00","pubTimestamp":1767708008,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA2KWDPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2601813890","title":"Guggenheim Initiates BillionToOne at Buy With $120 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2601813890","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601813890?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:19","pubTimestamp":1767705564,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc. Class A (BLLN) has an average rating of overweight and mean price target of $137.83, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic rese","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLLN"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":75,"code":"91000000","status":"200"}]}}